Galderma Investigational Site 6190

Madrid 28046

0 studies enrolling now · 3 studies all time

What they study most

Chronic Kidney Disease Associated Moderate to Severe Pruritus, Moderate-to-Severe Atopic Dermatitis

Studies at this site

• To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus — Completed
• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed